mirdametinib
Showing 1 - 6 of 6
Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)
Not yet recruiting
- Langerhans Cell Histiocytosis (LCH)
- +3 more
- Mirdametinib
- (no location specified)
Nov 22, 2023
Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)
Recruiting
- Low-Grade Glioma
- +2 more
- Mirdametinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 24, 2022
Breast Cancer, Breast Cancer Stage IV, HER2-negative Breast Cancer Trial in United States (Mirdametinib, Fulvestrant)
Recruiting
- Breast Cancer
- +6 more
- Mirdametinib
- Fulvestrant
-
Middletown, New Jersey
- +3 more
Dec 28, 2021
Solid Tumor, Adult Trial in Australia, United States (Lifirafenib, mirdametinib)
Recruiting
- Solid Tumor, Adult
- Lifirafenib
- mirdametinib
-
Santa Monica, California
- +5 more
Feb 22, 2022
Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,
Not yet recruiting
- Slow-Flow Vascular Malformation
- +17 more
- Alpelisib
- Mirdametinib
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Aug 7, 2023